Evaluation of recurrence score and traditional clinicopathologic assessments in a large ER-positive, lymph node-negative patient cohort.

被引：1
|
作者：
Liebermann, N.
Baehner, F. L.
Soussan-Gutman, L.
Klang, S.
Yoshizawa, C.
Shak, S.
Siegelmann-Danieli, N.
机构：
[1] Clalit Hlth Serv, Tel Aviv, Israel
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Teva Pharmaceut Ind, Netanya, Israel
[4] Genom Hlth, Redwood City, CA USA
[5] Maccabi Hlth Org, Tel Aviv, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.632
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
632
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
    Lamond, Nathan W. D.
    Skedgel, Chris
    Rayson, Daniel
    Lethbridge, Lynn
    Younis, Tallal
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (03) : 1115 - 1123
  • [32] A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
    Fujii, Takeo
    Masuda, Hiroko
    Cheng, Yee Chung
    Yang, Fei
    Sahin, Aysegul A.
    Naoi, Yasuto
    Matsunaga, Yuki
    Raghavendra, Akshara
    Sinha, Arup Kumar
    Fernandez, Jose Rodrigo Espinosa
    James, Anjali
    Yamagishi, Keisuke
    Matsushima, Tomoko
    Schuetz, Robert
    Tripathy, Debu
    Tada, Sachiyo
    Jackson, Rubie S.
    Noguchi, Shinzaburo
    Nakamura, Seigo
    Acoba, Jared D.
    Ueno, Naoto T.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (02) : 455 - 461
  • [33] Predictive factors for the occurrence of four or more axillary lymph node metastases in ER-positive and HER2-negative breast cancer patients with positive sentinel node: A retrospective cohort study
    Noda, Satoru
    Onoda, Naoyoshi
    Asano, Yuka
    Kurata, Kento
    Tokumoto, Mao
    Morisaki, Tamami
    Kashiwagi, Shinichiro
    Takashima, Tsutomu
    Hirakawa, Kosei
    INTERNATIONAL JOURNAL OF SURGERY, 2016, 26 : 1 - 5
  • [34] Clinical significance of 21-gene recurrence score assay for hormone receptor-positive, lymph node-negative breast cancer in early stage
    Yang Yu-qing
    Wang Lei
    Huang Mei-ling
    Xiao Jing-jing
    Wei Mei-chen
    Wu Jiang
    Hao Jun-sheng
    Ling Rui
    Li Nan-lin
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 108 : 150 - 155
  • [35] Predictive value of 21-gene recurrence score assay in non-estrogen receptor-positive and lymph node-negative breast cancer
    Lu, Kai
    Li, Hui
    Wu, Zhaoshu
    Liu, Dong
    Ye, Hongling
    Xu, Liang
    Liu, Yanwen
    JOURNAL OF BUON, 2018, 23 (05): : 1297 - 1301
  • [36] Can the Ki67 Proliferation Index Predict the Oncotype DX Recurrence Score in Lymph Node Negative, ER Positive Breast Cancer?
    Prendergast, A.
    Martin, K.
    Doolan, P.
    Clarke, C.
    Clynes, M.
    Evoy, D.
    McDermott, E.
    Crown, J.
    Kennedy, S.
    CANCER RESEARCH, 2011, 71
  • [37] Evaluation of 95-Gene Classifier of Formalin-fixed Paraffin-embedded Tissues in ER-positive, HER2-negative, and Node-negative Breast Cancer
    Yamashita, Hiroko
    Hatanaka, Kanako C.
    Yamagishi, Keisuke
    Saito, Yuria
    Hamasaki, Kengo
    Taniguchi, Mitsuru
    Okumura, Asami
    Nange, Ayae
    Matsuno, Yoshihiro
    Hatanaka, Yutaka
    ANTICANCER RESEARCH, 2023, 43 (02) : 707 - 711
  • [38] 25-year survival and benefit from tamoxifen therapy by the clinically used breast cancer markers in lymph node-negative and ER-positive/HER2-negative breast cancer
    Dar, H. A.
    Johansson, A.
    Nordenskoljd, A.
    Iftimi, A.
    Yau, C.
    Perez-Tenorio, G.
    Benz, C.
    Nordenskjold, B.
    Stal, O.
    Esserman, L.
    Fornander, T.
    Lindstrom, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S23 - S23
  • [39] Predictive value of the Theros Breast Cancer Index (TBCI) for distant recurrence and overall survival (OS) in comparison to Adjuvant! Online and clinicopathologic characteristics in women with lymph node (LN)-negative, ER-positive breast cancer (BCa)
    Jankowitz, R. C.
    Chivukula, M.
    Ma, X.
    Erlander, M. G.
    Mock, L. L.
    Mazur, L. S.
    Li, H.
    Salunga, R.
    Sereika, S.
    Brufsky, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Prognostic impact of the 21-gene recurrence score assay among young women with node-negative and node-positive ER+/HER2-breast cancer
    Poorvu, P. D.
    Gelber, S. I.
    Rosenberg, S. M.
    Ruddy, K. J.
    Tamimi, R. M.
    Collins, L. C.
    Peppercorn, J.
    Schapira, L.
    Borges, V. F.
    Come, S. E.
    Warner, E.
    Jakubowski, D. M.
    Russell, C.
    Winer, E. P.
    Partridge, A. H.
    CANCER RESEARCH, 2019, 79 (04)
12345